FDA Clearance Tracker · K223473
ME-APDS; MAGENTIQ-COLO
Last checked: Nov 19, 2026Latest source record: Jul 25, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Jul 25, 2023
Substantially Equivalent
Time to decision
250 days
Received Nov 17, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K223473
- Device name
- ME-APDS; MAGENTIQ-COLO
- Applicant
- Magentiq Eye, Ltd.
- Applicant location
- Haifa, IL
- Received
- Nov 17, 2022
- Decided
- Jul 25, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 876.1520
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QNP. The earliest in FDA's data is DEN200055, decided Apr 9, 2021.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K223473
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Magentiq Eye, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MAGENTIQ-COLO (ME-APDS)510(k)
K260724 · Decided Apr 3, 2026 · 29 days after receipt
Device type: Gastrointesinal Lesion Software Detection System (QNP) · GI, Urology & Nephrology
- MAGENTIQ-COLO (ME-APDS)510(k)
K252178 · Decided Oct 3, 2025 · 84 days after receipt
Device type: Gastrointesinal Lesion Software Detection System (QNP) · GI, Urology & Nephrology
- MAGENTIQ-COLO (ME-APDS)510(k)
K244023 · Decided Jan 24, 2025 · 28 days after receipt
Device type: Gastrointesinal Lesion Software Detection System (QNP) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.